Recall Register

Drug recall: Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3…

Class II FDA enforcement event 99101. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Glenmark Pharmaceuticals Inc., USA started this drug recall on 27 May 2026. The firm address in the FDA record is in Elmwood Park, NJ. FDA put the recall in Class II. FDA event 99101 has 1 product record. The first FDA enforcement report date is 24 Jun 2026. The record gives the status Ongoing. 79 of the 281 drug events that started in 2026 have more product records. The median drug event of 2026 has 1 product record.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

USA Nationwide.

Recalling firm

Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 99101: product records
Recall numberProductQuantityClassStatusReport date
D-0588-2026Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India, Manufactured for: Glenmark Pharmaceuticals Inc.,…Class IIOngoing24 Jun 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2026
281
Share of these events in Class II
75%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
56

Other events of the firm

Other FDA enforcement events of Glenmark Pharmaceuticals Inc., USA
InitiatedProduct (first record)TypeClassRecords
9 Oct 2026Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, ElmwoodDrugClass II1
23 Jul 2026Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA,DrugClass II1
30 Dec 2025Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, MaDrugClass II1
21 Nov 2025Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-87DrugClass III1
18 Nov 2025Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya PradDrugClass III1
17 Sep 2025Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited ColvalDrugClass II1
3 Sep 2025Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 BlisterDrugClass II1
8 Aug 2025Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals LimiteDrugClass II1
7 Aug 2025Carvedilol Tablets, USP, 3.125 mg, Packaged as: a)500-count bottle, NDC 68462-162-05; b) 100-count bottle, NDC 68462-162DrugClass II3
6 Aug 2025Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot DrugClass II2

Glenmark Pharmaceuticals Inc., USA: all 56 events

Official channels

Cite this page

Recall Register. FDA enforcement event 99101. https://recallregister.com/fda/ii/99101/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: USA Nationwide.
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2026 have the same class?
75% of the 281 drug events that started in 2026 are in Class II.
How many FDA recalls does Glenmark Pharmaceuticals Inc., USA have?
Glenmark Pharmaceuticals Inc., USA is the recalling firm in 56 enforcement events on this register. This event is 1 of them.